CU Anschutz Trial Shows AI Improves Hospital Oxygen Therapy
Aurora, Colorado, August 3, 2026 A University of Colorado Anschutz Medical Campus-led multicenter clinical trial has demonstrated that an...
Emergency Medicine
Advertisement
Novo Nordisk’s CagriSema Delivers Superior Diabetes Control
PLAINSBORO, New Jersey and BAGSVÆRD, Denmark, June 7, 2026 Novo Nordisk has reported compelling Phase 3 results demonstrating that...
Clarius Wins FDA Clearance for AI Cardiac Ultrasound Tool
VANCOUVER, British Columbia, June 2, 2026 Clarius Mobile Health has achieved a significant regulatory milestone with the U.S. Food...
RIVANNA Gains FDA Clearance for Accuro XV AI System
CHARLOTTESVILLE, Va., May 7, 2026 RIVANNA announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
Clear Scientific Gains FDA Fast Track for CS-1103
CAMBRIDGE, Mass., May 6, 2026 Clear Scientific Inc., a clinical-stage biopharmaceutical company developing innovative therapies for acute drug intoxication,...
Advertisements
Emergent Expands NARCAN Supply in BC Opioid Program
WINNIPEG, Manitoba, April 9, 2026 Emergent BioSolutions Inc. has announced a strategic partnership with the British Columbia Provincial Health...
ARS Pharma: FDA Removes Age Limit for neffy Use
SAN DIEGO, March 27, 2026 ARS Pharmaceuticals has received U.S. FDA approval to update the labeling of neffy® (epinephrine...
FDA Approves ZOLL Zenix Defibrillator to Advance Cardiac Care
CHELMSFORD, Mass., Sept. 30, 2025 — The U.S. Food and Drug Administration (FDA) has approved the ZOLL Zenix Monitor/Defibrillator,...
Advertisement
